Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ADMA Biologics, Inc.

ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Amendment to Credit Agreement
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Proposed Public Offering of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.